TVTX and LGND Related Headlines

Feb 27, 2024 07:00AM Ligand Reports Fourth Quarter and Full Year 2023 Financial Results

Nov 8, 2023 04:01PM Ligand Reports Third Quarter 2023 Financial Results

Sep 21, 2023 09:21AM Travere Therapeutics (TVTX) Reports Confirmatory Data from the Phase 3 PROTECT Study of FILSPARI

Sep 21, 2023 09:20AM Ligand’s Partner Travere Therapeutics Announces Confirmatory Data from the Phase 3 PROTECT Study of FILSPARI® Demonstrating Long-Term Kidney Function Preservation in IgA Nephropathy; Narrowly Missi

Aug 8, 2023 04:01PM Ligand Reports Second Quarter 2023 Financial Results

May 4, 2023 04:01PM Ligand Reports First Quarter 2023 Financial Results

TVTX and LGND Related Press Releases

Feb 27, 2024 07:00AM Ligand Reports Fourth Quarter and Full Year 2023 Financial Results

Nov 8, 2023 04:01PM Ligand Reports Third Quarter 2023 Financial Results

Sep 21, 2023 09:20AM Ligand’s Partner Travere Therapeutics Announces Confirmatory Data from the Phase 3 PROTECT Study of FILSPARI® Demonstrating Long-Term Kidney Function Preservation in IgA Nephropathy; Narrowly Missi

Aug 8, 2023 04:01PM Ligand Reports Second Quarter 2023 Financial Results

May 4, 2023 04:01PM Ligand Reports First Quarter 2023 Financial Results

TVTX and LGND Related SEC Filings